UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
______________
FORM
8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT
TO SECTION 12(b) OR 12(g) OF THE
SECURITIES
EXCHANGE ACT OF 1934
BODISEN
BIOTECH, INC.
(Exact
name of registrant as specified in its charter)
Delaware
(State
of incorporation or organization)
|
98-0391367
(I.R.S.
Employer Identification No.)
|
North
Part of Xinquia Road, Yang
Ling
Agricultural High-Tech Industries
Demonstration
Zone, Yang Ling, People's Republic of China
(Address
of principal executive offices)
|
712100
(Zip
Code)
|
Securities
to be registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Name
of exchange on which
|
to
be registered
|
each
class is to be registered
|
Common
Stock
|
American
Stock Exchange
|
If
this
form relates to the registration of a class of securities pursuant to Section
12(b) of the Exchange Act and is effective pursuant to General Instruction
A.
(c), check the following box. [X]
If
this
form relates to the registration of a class of securities pursuant to Section
12(g) of the Exchange Act and is effective pursuant to General Instruction
A.
(d), check the following box. [ ]
Securities
Act registration statement file number to which this form relates: ________
(if
applicable)
Securities
to be registered pursuant to Section 12(g) of the Act:
None
(Title
of
Class)
Item
1. Description of Registrant's Securities to be
Registered.
The
securities to be registered are Bodisen Biotech, Inc.’s (the “Registrant”)
common
stock, par value $.0001 per share. As of August 23, 2005, the Registrant
had
15,310,824 common shares issued and outstanding. All common shares rank equally
as to (i) voting rights, (ii) dividend rights, and (iii) participation in
a
distribution of assets from the Registrant in the event of a liquidation,
dissolution or winding-up of the Registrant.
Distributions
in the form of dividends, if any, are determined by the Registrant’s board of
directors.
Each
holder of common shares is entitled to receive notice and to attend and vote
at
all meetings of shareholders of the Registrant. Each common share carries
with
it the right to one vote. The common shares do not have cumulative voting,
pre-emptive, purchase or conversion rights.
Item
2. Exhibits.
Pursuant
to the Instructions as to Exhibits, no Exhibits are filed herewith or
incorporated herein by reference.
SIGNATURE
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934,
the
registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized.
|
|
|
|
BODISEN
BIOTECH, INC. |
|
|
|
Date: August
25, 2005 |
By: |
/s/ Qiong
Wang |
|
Qiong
Wang |
|
Chief
Executive Officer |